|
⚲
|
| Keyboard |
| Sendek Joel
✚
|
|
|---|---|
| CIK # | 0001720875 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001720875] | |
| 4 | [0001720875] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sendek Joel | |
| Spero Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Spero Therapeutics Inc SPRO
Stock Option (Right to Buy · derivative
|
2019-01-02 | Grant | 65,000 | $0.00 | |
|
Spero Therapeutics Inc SPRO
Common Stock
|
2018-07-05 | Option exercise | 2,000 | $5.90 | 11,800 |
|
Spero Therapeutics Inc SPRO
Common Stock
|
2018-07-05 | Sell | 2,000 | $17.50 | 35,000 |
|
Spero Therapeutics Inc SPRO
Stock Option (Right to Buy) · derivative
|
2018-07-05 | Option exercise | 2,000 | $0.00 | |
|
Spero Therapeutics Inc SPRO
Stock Option (Right to Buy) · derivative
|
2017-12-13 | Grant | 27,795 | $0.00 | |
|
Spero Therapeutics Inc SPRO
Common Stock
|
2017-11-06 | Conversion | 10,181 | ||
|
Spero Therapeutics Inc SPRO
Common Stock
|
2017-11-06 | Buy | 5,000 | $14.00 | 70,000 |
|
Spero Therapeutics Inc SPRO
Series C Preferred Stock · derivative
|
2017-11-06 | Conversion | 61,880 | $0.00 |